Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Purpura, Thrombocytopenic, Idiopathic and Hepatitis C”

5 trials

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT01762761
What this trial is testing

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic and Hepatitis C
Novartis Pharmaceuticals 155
Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Not applicableUnknownNCT04113915
What this trial is testing

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Who this might be right for
ITP - Immune Thrombocytopenic PurpuraViral Hepatitis
Safaa AA Khaled 150
Not applicableEnrolling By InvitationNCT02422875
What this trial is testing

Comparative Autoantibody and Immunologic Cell Marker Study

Who this might be right for
Autoimmune DiseasesLupus Erythematosus, SystemicCommunicable Diseases
Emory University 2,500
Not applicableAvailableNCT04837703
What this trial is testing

Managed Access Programs for ETB115, Eltrombopag

Who this might be right for
Thrombocytopenia
Novartis Pharmaceuticals

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation